Brand name · GIP / GLP-1 Dual Agonist
Zepbound J-Code / HCPCS Code
In short
Med-Code's directory has no drug-specific HCPCS code for Zepbound. It is usually self-administered and billed by NDC through a pharmacy benefit. Where a payer accepts an unclassified code for it in a clinical setting, that code is J3490 (Unclassified drugs), reported with the NDC and quantity.
Reference
- Code
- J3490 — Unclassified drugsMed-Code curated
- Billing unit
- No defined unit — report the NDC and quantity
- Same code in the directory
- Mounjaro, Ozempic, Semaglutide, Tirzepatide, Wegovy
- Pharmacologic class
- GLP-1 Receptor Agonist; Glucose-dependent Insulinotropic Polypeptide Receptor AgonistFrom the FDA listings below
- Labelers
- Eli Lilly and Company
- J-code category
- GIP / GLP-1 Dual Agonist
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zepboundtirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2471 |
| Zepbound KwikPentirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3555 |
| Zepboundtirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1214 |
| Zepboundtirzepatide | Tirzepatide 10 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1340 |
| Zepboundtirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6103 |
| Zepboundtirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6612 |
| Zepbound KwikPentirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3533 |
| Zepbound KwikPentirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3566 |
| Zepboundtirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-0243 |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2002 |
| Zepboundtirzepatide | Tirzepatide 15 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2457 |
| Zepboundtirzepatide | Tirzepatide 7.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2484 |
| Zepboundtirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6052 |
| Zepboundtirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2506 |
| Zepboundtirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6304 |
| Zepbound KwikPentirzepatide | Tirzepatide 25 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3511 |
| Zepbound KwikPentirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3544 |
| Zepboundtirzepatide | Tirzepatide 2.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-0152 |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1423 |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2460 |
| Zepboundtirzepatide | Tirzepatide 5 mg/.5mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-2495 |
| Zepboundtirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6210 |
| Zepboundtirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-6523 |
| Zepbound KwikPentirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3522 |